← All organizations
Hamilton Health Sciences Corporation
Academic/HospitalWebsite ↗
Also known as: Gail Gauvreau | Hamilton Health Sciences Corporation | Hamilton Health Sciences Foundation - New Investigator Fund | Hamilton Health Sciences - Juravinski Hospital | Juravinski Cancer Centre at Hamilton Health Sciences Centre, ON Canada | Juravinski Cancer Centre at Hamilton Health Sciences, Ontario Canada | Michael G. DeGroote Pain Clinic, Hamilton Health Sciences
Highest phase reached
Phase 4
First clinical trial
Jul 1, 1997Last known activity
Feb 1, 2026
Timeline
1990s
- Jan 1, 1996
Hamilton Health Sciences Corporation— Founded
Drugs by trial phase (159 distinct, 152 trials)
Phase 4 (37 own, 0 via acquisition)
Phase 3 (49 own, 0 via acquisition)
Phase 2 (40 own, 0 via acquisition)
Phase 1 (12 own, 0 via acquisition)
Other trials (21 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Acute Pain
- Adenocarcinoma
- Agoraphobia
- Alzheimer Disease
- Antiphospholipid Syndrome
- Anxiety Disorders
- Apnea
- Asthma
- Atherosclerosis
- Atrial Fibrillation
- Atrial Flutter
- Azotemia
- Beriberi
- Bipolar Disorder
- Breast Neoplasms
- Cardiovascular Diseases
- Cerebral Infarction
- Cholestasis
- Chronic Pain
- Clostridium Infections
- Colitis
- Colitis, Ulcerative
- Compulsive Personality Disorder
- Connective Tissue Diseases
- Coronary Artery Disease
- Critical Illness
- Delirium
- Depression
- Depressive Disorder
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diarrhea
- Disease
- Dyspnea
- Edema
- Femoral Neck Fractures
- Fractures, Bone
- Heart Diseases
- Heart Failure
- Heart Valve Diseases
- Hematoma
- Hemolysis
- Hemolytic-Uremic Syndrome
- Hemorrhage
- Hip Fractures
- HIV Infections
- Hypersensitivity
- Hypertension
- Hypertension, Pulmonary
- Hypoproteinemia
- Infarction
- Inflammation
- Ischemia
- Kidney Diseases
- Kidney Failure, Chronic
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Liver Diseases
- Macular Degeneration
- Major Depressive Disorder
- Marijuana Abuse
- Muscle Spasticity
- Myocardial Infarction
- Obsessive-Compulsive Disorder
- Osteoarthritis, Knee
- Otitis
- Otitis Media
- Otitis Media with Effusion
- Panic Disorder
- Phobia, Social
- Phobic Disorders
- Pneumonia
- Postoperative Pain
- Premenstrual Dysphoric Disorder
- Prostatic Neoplasms
- Purpura
- Purpura, Thrombocytopenic
- Purpura, Thrombocytopenic, Idiopathic
- Purpura, Thrombotic Thrombocytopenic
- Renal Insufficiency
- Renal Insufficiency, Chronic
- Respiratory Tract Infections
- Schizophrenia
- Sepsis
- Seroma
- Shock
- Shock, Septic
- Sleep Apnea, Obstructive
- Sleep Apnea Syndromes
- Stroke
- Syndrome
- Tachycardia
- Tachycardia, Ventricular
- Thiamine Deficiency
- Thrombocytopenia
- Thromboembolism
- Thrombosis
- Toxemia
Recent trials (50)
- NCT07118696Lead sponsorPhase 3Feb 1, 2026
- NCT07145645CollaboratorPhase 3Sep 2, 2025
- NCT06908694Lead sponsorPhase 4Jul 2, 2025
- NCT06836024Lead sponsorPhase 2/Phase 3Jun 1, 2025
- NCT06836024OfficialPhase 2/Phase 3Jun 1, 2025
- NCT06622564Lead sponsorPhase 3Jan 1, 2025
- NCT06567808OfficialPhase 4Dec 31, 2024
- NCT06567808Lead sponsorPhase 4Dec 31, 2024
- NCT06569225CollaboratorPhase 2Dec 15, 2024
- NCT06495294CollaboratorN/AAug 31, 2024
- NCT07143201Sponsor investigatorPhase 2Jul 4, 2024
- NCT07143201Lead sponsorPhase 2Jul 4, 2024
- NCT06353529Lead sponsorPhase 4May 31, 2024
- NCT06203977Lead sponsorPhase 1May 1, 2024
- NCT06359197Lead sponsorEarly Phase 1Apr 8, 2024
Details
- Founded
- Hamilton, CA Jan 1, 1996
- Last known activity
- Feb 1, 2026